ReadYourDNA

rs6313 (HTR2A)

What you carry at this position in your DNA and what research says about it.

Serotonin Receptor Function: 5/10 evidence, 60 publications.

You're viewing every possible genotype for this variant.

None of these is your result. Use the genotype toggle to compare them, then sign up and upload your DNA to see which one is yours.

Sample genotype (not yours): G/G

Higher Joint Inflammation Risk but Better Medication Tolerability

Susceptibility to joint inflammation is slightly elevated, but there is a lower risk of metabolic side effects from certain medications. Serotonin signaling remains at a stable baseline.

What this genotype means: Elevated risk of rheumatoid arthritis; Lower risk of risperidone-induced weight gain; Typical emotional stress resilience.

Sample genotype (not yours): A/A

Higher Stress Sensitivity and Medication Side Effect Risk

Sensitivity to emotional stress, panic, and mood fluctuations is elevated. There is also a higher likelihood of experiencing side effects from common antidepressants.

What this genotype means: Increased sensitivity to stress and panic; Higher risk of antidepressant-induced sexual dysfunction; Typical risk of rheumatoid arthritis.

Sample genotype (not yours): G/A

Increased Joint Inflammation and Medication Side Effect Risk

Susceptibility to joint inflammation is slightly elevated, and there is a higher likelihood of experiencing metabolic side effects from certain medications. Emotional stress responses remain typical.

What this genotype means: Elevated risk of rheumatoid arthritis; Higher risk of risperidone-induced weight gain; Potentially reduced response to sertraline.

About HTR2A

Gene function and biological role

Gene Function: The HTR2A gene encodes the 5-hydroxytryptamine receptor 2A, a major G-protein-coupled receptor for serotonin widely expressed throughout the central nervous system and peripheral tissues [1]. This receptor plays a fundamental role in modulating mood, anxiety, perception, and cognitive processes by regulating synaptic neurotransmission [2]. Beyond its neurological functions, the receptor is also expressed on platelets and immune cells, where it participates in inflammatory pathways and vascular responses [3]. Because of its diverse physiological roles, variations in this gene are heavily studied in relation to psychiatric conditions, personality traits, and autoimmune susceptibility [4].

Variant Impact: The rs6313 variant is a synonymous single nucleotide polymorphism located in exon 1 of the HTR2A gene, often referred to in scientific literature as the T102C or C102T polymorphism [1]. Although it does not alter the encoded serine amino acid at position 34, this genetic change is in tight linkage disequilibrium with regulatory variants that influence HTR2A promoter activity and gene expression levels [5]. The minor A allele (corresponding to the T allele in older literature) has been associated with altered receptor density and splice isoform expression in the human cortex [1]. Consequently, this variant serves as a key genetic marker for individual differences in serotonin signaling, emotional processing, and drug response [6].

Key Insight: A silent genetic change that does not alter any amino acids can still significantly impact receptor expression levels and drug sensitivity. The same serotonin receptor that regulates mood also influences immune cell activation in joint tissue.

Location: HTR2A. Chromosome 13 · 13q14.2 · 46.9 Mb

Genotype Frequencies

Estimated prevalence by population

Global 36.0%; European 34.8%; African 38.8%; East Asian 17.2%; South Asian 34.2%; Americas 37.2%; Ashkenazi 25.3%; Finnish 44.1%; Middle Eastern 22.4%; Amish 60.7%.

Estimated GG genotype frequency.

Global 47.6%; European 48.4%; African 47.0%; East Asian 48.5%; South Asian 48.6%; Americas 47.6%; Ashkenazi 50.0%; Finnish 44.6%; Middle Eastern 49.9%; Amish 34.4%.

Estimated GA genotype frequency.

Global 16.3%; European 16.8%; African 14.2%; East Asian 34.3%; South Asian 17.2%; Americas 15.2%; Ashkenazi 24.7%; Finnish 11.3%; Middle Eastern 27.8%; Amish 4.9%.

Estimated AA genotype frequency.

Associated Traits

Showing effects for G/G genotype

Immunity & Inflammation

Autoimmune Diseases

Rheumatoid Arthritis. Evidence: 3/10. Source: PMID 18006541. Increased Risk.

Neurology & Mental Health

Anxiety & Stress Disorders

Stress and Panic. Evidence: 3/10. Source: PMID 21930285. Typical.

Pharmacogenomics

Antidepressant & Psychiatric Drug Response

Antipsychotic Weight Gain. Evidence: 5/10. Source: PMID 16633140. Lower Risk.

Antidepressant Response. Evidence: 5/10. Source: PMID 31792367. Typical.

Showing effects for A/A genotype

Rheumatoid Arthritis. Evidence: 3/10. Source: PMID 18006541. Typical Risk.

Stress and Panic. Evidence: 3/10. Source: PMID 21930285. Higher Sensitivity.

Antipsychotic Weight Gain. Evidence: 5/10. Source: PMID 16633140. Higher Risk.

Antidepressant Response. Evidence: 5/10. Source: PMID 31792367. Higher Side Effects.

Showing effects for G/A genotype

What GG Genotype Means

What this genotype means for the people who carry it

Sample genotype: GG (Homozygous)

Autoimmune pathways show a higher baseline of activation, which has been linked to an increased susceptibility to rheumatoid arthritis in European populations [1]. This genetic profile is associated with higher expression of the HTR2A receptor, which can influence peripheral immune responses and joint tissue inflammation [1]. However, in psychiatric contexts, this baseline receptor density is associated with a lower risk of metabolic side effects [2]. Specifically, clinical studies indicate a significantly reduced risk of experiencing severe weight gain when treated with atypical antipsychotics like risperidone [3]. Standard antidepressant therapies also tend to be well-tolerated, with a lower incidence of common side effects compared to other genotypes [4].

Elevated risk of rheumatoid arthritis; Lower risk of risperidone-induced weight gain; Typical emotional stress resilience.

What AA Genotype Means

Sample genotype: AA (Homozygous)

Serotonin receptor density in the prefrontal cortex is altered, which can influence emotional reactivity and stress resilience [1]. This genetic profile is frequently associated with a higher susceptibility to panic symptoms, anxiety, and seasonal mood changes [2]. In clinical settings, these receptor differences translate to a distinct medication response profile [3]. Individuals with this genotype are more prone to specific side effects, such as citalopram-induced sexual dysfunction [3]. There is also an increased risk of metabolic side effects, including significant weight gain, during treatment with atypical antipsychotics like risperidone [4]. Conversely, there is a lower risk of joint inflammation, as this genotype is not associated with the elevated rheumatoid arthritis risk seen in G allele carriers [5].

Increased sensitivity to stress and panic; Higher risk of antidepressant-induced sexual dysfunction; Typical risk of rheumatoid arthritis.

What GA Genotype Means

Sample genotype: GA (Heterozygous)

Susceptibility to autoimmune joint issues is slightly elevated due to the presence of the G allele, which is associated with higher inflammatory signaling in joint tissues [1]. This genetic pattern can lead to increased production of inflammatory cytokines like TNF-alpha and IL-6 in response to immune triggers [1]. On the pharmacogenomic front, carrying one copy of the A allele alters how the body responds to psychiatric medications [2]. Clinical trials show an increased risk of experiencing significant weight gain when taking antipsychotic medications such as risperidone [3]. Additionally, certain selective serotonin reuptake inhibitors, like sertraline, may be less effective [4].

Elevated risk of rheumatoid arthritis; Higher risk of risperidone-induced weight gain; Potentially reduced response to sertraline.

Related Variants

Variants with shared genetic architecture

rs6311 · HTR2A Gene · Chr 13 · Antidepressant Side Effects

rs6314 · HTR2A Gene · Chr 13 · Episodic Memory

rs7997012 · HTR2A Gene · Chr 13 · Antidepressant Response

Sources

Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex.

Variations in 5-HT2A influence spatial cognitive abilities and working memory.

Genetic variations in the serotonin 5-HT2A receptor gene (HTR2A) are associated with rheumatoid arthritis.

The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment--a European multicentre study.

Association of genetic, psychological and behavioral factors with sleep bruxism in a Japanese population.

Temperament profiles, 5-HT2A genotype, and response to treatment with SSRIs in major depression.

Risperidone-related weight gain: genetic and nongenetic predictors.

Predictive Role of Serotonin Receptor (5HTR2A) and Dopamine Receptor (DRD2) gene polymorphisms in risperidone-induced weight gain and hyperprolactinemia in patients with schizophrenia.

Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy.

The CC genotype in HTR2A T102C polymorphism is associated with behavioral impulsivity in alcohol-dependent patients.

Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.

Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients.

Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive Disorders.

Back to Variant Explorer

Content updated August 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com